Partner Headlines - PGNX

  1. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  2. Earnings Scheduled For August 8, 2014

    Benzinga
  3. Morning Market Movers

    Benzinga
  4. Benzinga's Top #PreMarket Gainers

    Benzinga
  5. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga
  6. UPDATE: Salix, Progenics Report FDA Office Of Drug Evaluation ...

    Benzinga
  7. Progenics Announces Will Host Call Related to FDA Appeal Response ...

    Benzinga
  8. Progenics, Nektar Still Halted; FDA Advisory Committee Expected ...

    Benzinga
  9. Small Pharmaceuticals Rallying Following FDA Report

    Benzinga
  10. Mid-Afternoon Market Update; Hertz Down, QuikSilver Gain On CEO ...

    Benzinga
  11. Mid-Day Market Update: Diamond Foods Shares Fall After Weak Earnings; ...

    Benzinga
  12. Earnings Scheduled For May 9, 2014

    Benzinga
  13. Progenics Pharmaceuticals Announces Completion of Enrollment ...

    Benzinga
  14. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  15. Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the ...

    Benzinga
  16. Earnings Scheduled For March 13, 2014

    Benzinga
  17. 2 Deaths, 25% Plunge -- And Still A Big Upside

    YCharts
  18. Progenics Pharmaceuticals Announces the Appointment of Karen ...

    Benzinga
  19. Progenics Pharmaceuticals Relaunches Registrational Trial of ...

    Benzinga
  20. Earnings Scheduled For November 11, 2013

    Benzinga
  21. Salix Pharmaceuticals Thrives With Promising GI Drugs

    IBD
  22. Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX

    GuruFocus
  23. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  24. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  25. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  26. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  27. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  28. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  29. Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  30. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  31. Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX

    GuruFocus
  32. Progenics Pharmaceuticals Inc. (PGNX) CEO Mark Robert Baker buys ...

    GuruFocus
  33. 5 Stocks That Dropped the Most Since Gurus Bought Them

    GuruFocus
  34. EZchip Semiconductor, Sagent Pharmaceuticals Among Stocks setting ...

    FoxBusiness
  35. Salix trounces Q2 estimates

    IBD
  36. Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  37. Salix Pharmaceuticals Beats, Announces Licensing Deal

    IBD
  38. ProShares Trust Ultra VIX Short Term Futures ETF, Direxion Daily ...

    FoxBusiness
  39. Stocks Finish Little Changed Ahead of Central Bank Meetings with ...

    MarketIntelligenceCenter
  40. Salix, Progenics Stocks Fall On Drug Approval Delay

    IBD
  41. Stock Futures Mixed; Salix, Progenics Tumble

    IBD
  42. Benzinga's Top Pre-Market Losers

    Benzinga
  43. Financial Breakfast: Morning News Summary for July 30, 2012

    Benzinga
  44. Salix Q1 Results Beat Estimates; Raises EPS Guidance

    IBD
  45. Microcap Movers for Tuesday December 20, 2011

    Benzinga
  46. Stocks Bounce Back In Big Volume

    IBD
  47. Progenics Pharma Up 30% on Positive Phase 3 Results

    Benzinga
  48. Notable Call Options Activity in Progenics Pharmaceuticals

    Benzinga
  49. Morning Market Movers

    Benzinga
  50. Progenics Pharmaceuticals Lures Call Players in the Options Pits

    SchaeffersResearch
  51. Notable Call Options Activity in Progenics Pharmaceuticals

    Benzinga
Trading Center